Coya Therapeutics, Inc. Common Stock
COYA
$4.34+3.83%
End of day · as of Oct 15, 2026, 9:15 PM ET
Mkt cap
$117.99M
EV/Sales
8.96
P/E ratio
N/A
FY2025 Revenue
$7.95M
EPS (TTM)
$-1.07
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-267.14%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
Use this COYA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full COYA income, balance, and cash tables.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company in the Healthcare sector.
Latest cached Coya Therapeutics, Inc. Common Stock (COYA) revenue for Dec 31, 2025 was $7.9M. Net income was -$21.2M. Statements: https://lician.com/financials/coya
Coya Therapeutics, Inc. Common Stock (COYA) market capitalization is $118.0M on the latest cached snapshot.
Coya Therapeutics, Inc. Common Stock (COYA) cached previous close $4.18; day range $4.18 – $4.34; volume 236,120. Session quote: https://lician.com/quote/coya
Coya Therapeutics, Inc. Common Stock (COYA) latest cached earnings event is "COYA earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached COYA filing is 8-K · Oct 14, 2026. Filings: https://lician.com/sec/coya